Skip to content
Condition

Retinitis Pigmentosa

Retinitis pigmentosa (RP) is a group of rare, inherited eye diseases that cause progressive vision loss. It damages the retina, the light-sensitive tissue at the back of the eye, leading to a breakdown of cells responsible for sight. Symptoms often begin with difficulty seeing at night and a gradual loss of side (peripheral) vision.

What is Retinitis Pigmentosa?

Retinitis pigmentosa (RP) is a collection of inherited eye disorders that progressively damage the retina, the specialized tissue at the back of your eye responsible for detecting light. This damage leads to a slow, worsening loss of vision, typically starting with challenges seeing in low light and a reduction in your side vision.

Your retina contains millions of light-sensing cells called photoreceptors. These include rods, which help you see in dim light and detect peripheral (side) vision, and cones, which are responsible for bright light, color vision, and sharp central vision. In retinitis pigmentosa, these photoreceptor cells, or the cells that support them, gradually break down over time. Because RP is a group of diseases, the specific cells affected and the rate of vision loss can vary. Most forms of RP first affect the rod cells, leading to early symptoms related to night and peripheral vision. As the condition progresses, cone cells may also be affected, impacting central vision and color perception. This condition is considered rare, affecting about 1 in 4,000 people (0.025%) in the United States. It is a lifelong condition that slowly worsens, and there is currently no cure, though treatments can help manage symptoms and, in some cases, slow progression. (MedlinePlus, Mayo Clinic)

Symptoms

The primary symptoms of retinitis pigmentosa typically begin with difficulty seeing in dim light or at night, known as night blindness (nyctalopia). Over time, individuals also experience a gradual loss of side (peripheral) vision, which can narrow their field of view, creating what is often described as "tunnel vision."

Night blindness is often the first symptom to appear, sometimes starting in childhood or adolescence. You might find it increasingly difficult to see when driving at dusk, walking in dimly lit rooms, or navigating at night. This happens because the rod cells, which are crucial for low-light vision, are usually the first to be affected. As the disease progresses, you will likely notice a loss of your peripheral vision. This means your side vision gradually shrinks, making it harder to see things outside your direct line of sight. This can lead to bumping into objects, tripping, or difficulty navigating crowded spaces. This narrowing of vision is often referred to as "tunnel vision." Later in the disease course, the cone cells, responsible for central vision and color perception, may also be affected. This can lead to difficulty with tasks requiring sharp vision, such as reading, recognizing faces, or distinguishing colors. Some people may also experience increased sensitivity to bright light (photophobia) or glare. (MedlinePlus, Mayo Clinic)

Causes & risk factors

Retinitis pigmentosa is caused by specific changes (mutations) in genes that are vital for the healthy function of your retina. It is an inherited condition, meaning it is passed down through families from parents to children. Therefore, having a family history of RP is the main risk factor for developing the condition.

Scientists have identified mutations in over 100 different genes that can cause retinitis pigmentosa. Each of these genes plays a role in the development or function of the photoreceptor cells in the retina. When a gene has a mutation, it can lead to the breakdown of these cells. RP can be inherited in several ways: autosomal dominant, autosomal recessive, or X-linked. In autosomal dominant inheritance, only one copy of a mutated gene from one parent is needed to cause the condition. In autosomal recessive inheritance, two copies of a mutated gene, one from each parent, are required. X-linked RP occurs when the mutated gene is on the X chromosome, primarily affecting males. In some cases, RP can occur without a known family history, possibly due to a new (spontaneous) gene mutation. However, a family history of retinitis pigmentosa is the most significant risk factor. RP can also be part of a larger genetic syndrome, such as Usher syndrome, which also involves hearing loss. (MedlinePlus, Mayo Clinic)

How it's diagnosed

Diagnosing retinitis pigmentosa typically involves a comprehensive eye examination by an ophthalmologist, including specialized tests to assess retinal function and structure. These tests often include visual field testing to check side vision and an electroretinogram (ERG) to measure the electrical activity of the retina. Genetic testing can confirm the specific gene mutation.

During a comprehensive eye exam, your eye doctor will dilate your pupils to get a clear view of your retina. They may observe characteristic pigment deposits in the retina, which are a hallmark of RP. They will also ask about your symptoms, especially any difficulty seeing at night or changes in your peripheral vision. Several specialized tests are used to confirm the diagnosis and assess the extent of the condition. A visual field test measures your peripheral vision and helps identify areas of vision loss. An electroretinogram (ERG) measures the electrical responses of the retina's light-sensing cells to flashes of light, indicating how well these cells are functioning. Optical coherence tomography (OCT) is another imaging test that provides detailed cross-sectional images of the retina, allowing the doctor to see the layers of the retina and detect any thinning or damage. Genetic testing is crucial for a definitive diagnosis. It involves a blood or saliva sample to identify the specific gene mutation causing the RP. Knowing the exact genetic cause can help predict the disease's progression and determine if you are eligible for specific gene therapies. (MedlinePlus, Mayo Clinic)

Treatment options

Currently, there is no cure for retinitis pigmentosa, but various treatments aim to slow its progression, manage symptoms, and help individuals adapt to vision loss. These options range from nutritional supplements and low vision aids to advanced gene therapies and retinal implants for specific genetic types.

Certain nutritional supplements may be recommended to potentially slow the progression of RP. High-dose Vitamin A palmitate has been studied, but its use requires careful medical supervision due to potential toxicity, especially to the liver. Some studies also suggest a possible benefit from omega-3 fatty acids, such as docosahexaenoic acid (DHA), sometimes in combination with Vitamin A. Always discuss any supplements with your doctor, as high doses can be harmful. (MedlinePlus, Mayo Clinic, Cochrane Library) For managing vision loss, low vision aids and vision rehabilitation services are essential. These can include specialized magnifiers, telescopic lenses, adaptive computer software, and training to help you use your remaining vision more effectively. Occupational therapists can also help you adapt your home and daily routines to improve safety and independence. Breakthroughs in gene therapy offer hope for specific forms of RP. For example, voretigene neparvovec (Luxturna) is a gene therapy approved for individuals with RP caused by mutations in the RPE65 gene. This treatment can improve vision in eligible patients. For people with very advanced RP and significant vision loss, retinal implants, such as the Argus II (often called a "bionic eye"), can restore some light perception. These devices work by converting images into electrical pulses that stimulate the remaining retinal cells. (MedlinePlus, Mayo Clinic, Cochrane Library) Ongoing clinical trials are exploring other potential treatments, including different gene therapies, stem cell therapies, and neuroprotective agents. Your doctor can provide information on whether you might be a candidate for any of these emerging options. (Mayo Clinic)

Recovery & outlook

Retinitis pigmentosa is a progressive condition, meaning vision loss worsens over time, and it can eventually lead to significant visual impairment or legal blindness. There is no recovery of lost vision. However, the rate and severity of vision loss vary widely among individuals, depending on the specific genetic cause and when symptoms begin.

The outlook for individuals with retinitis pigmentosa is highly variable. While most people will experience progressive vision loss, many retain some useful vision for decades. The specific gene mutation, the age of symptom onset, and the type of RP all influence how quickly vision declines and how much vision is ultimately lost. For many, night blindness and peripheral vision loss are the most prominent features for a long time. Central vision may remain relatively good until later stages of the disease. However, some forms of RP can lead to earlier and more severe central vision loss. Living with RP involves adapting to changing vision. This includes using low vision aids, learning new ways to perform daily tasks, and accessing support services. While there is no cure, ongoing research, particularly in gene therapy, offers hope for future treatments that may slow or even stop the progression of certain types of RP. Regular follow-up with an eye care specialist is crucial to monitor the condition and explore new treatment options as they become available. (MedlinePlus, Mayo Clinic)

When to see a doctor

You should see an eye doctor if you notice any changes in your vision, especially if you experience difficulty seeing at night or in dim light, or if you observe a gradual loss of your side (peripheral) vision. Early diagnosis of retinitis pigmentosa can help in managing the condition and exploring potential treatments.

It is important to schedule an appointment with an ophthalmologist if you or a family member notice any of the key symptoms of retinitis pigmentosa. These include: difficulty adapting to dark environments, frequent tripping or bumping into objects due to not seeing things to your side, or any significant changes in your overall vision. If you have a family history of retinitis pigmentosa, even if you don't have symptoms, regular comprehensive eye exams are recommended. Early detection allows for monitoring of the condition and discussion of any available interventions that might slow progression or manage symptoms. While RP is not a medical emergency, prompt evaluation of vision changes is always advisable. An eye care professional can determine the cause of your symptoms and provide appropriate guidance and care. (MedlinePlus, Mayo Clinic)

Frequently asked questions

Is Retinitis Pigmentosa always inherited?

Yes, retinitis pigmentosa is primarily an inherited condition, meaning it is caused by genetic mutations passed down through families. While it can sometimes appear without a known family history due to a new (spontaneous) gene mutation, the underlying cause is always genetic. (MedlinePlus, Mayo Clinic)

Can children get Retinitis Pigmentosa?

Yes, retinitis pigmentosa can affect children. Symptoms often begin in childhood or adolescence, with night blindness being one of the earliest signs. The age of onset and the rate of progression can vary widely depending on the specific genetic mutation. (Mayo Clinic)

Are there different types of Retinitis Pigmentosa?

Yes, retinitis pigmentosa is not a single disease but a group of related genetic disorders. There are many different types, each caused by mutations in specific genes (over 100 identified) and inherited in various patterns, such as autosomal dominant, autosomal recessive, or X-linked. (MedlinePlus, Mayo Clinic)

Will I go completely blind with Retinitis Pigmentosa?

Not everyone with retinitis pigmentosa will experience complete blindness. While it is a progressive condition that can lead to significant vision impairment or legal blindness, many individuals retain some useful vision throughout their lives. The extent of vision loss varies greatly depending on the specific genetic cause. (Mayo Clinic)

What is the role of genetic testing in Retinitis Pigmentosa?

Genetic testing plays a crucial role in diagnosing retinitis pigmentosa by identifying the specific gene mutation responsible for the condition. This information can help confirm the diagnosis, predict the disease's progression, and determine eligibility for specific gene therapies, such as Luxturna for RPE65 mutations. (MedlinePlus, Mayo Clinic)

Are there any lifestyle changes that can help manage Retinitis Pigmentosa?

While there are no specific lifestyle changes that can cure retinitis pigmentosa, adapting your environment and daily routines can help manage symptoms. This includes using low vision aids, ensuring good lighting, and working with vision rehabilitation specialists. Any dietary supplements, like Vitamin A, should only be taken under strict medical supervision. (Mayo Clinic, Cochrane Library)

Sources

  • MedlinePlus — Retinitis Pigmentosa
  • Mayo Clinic — Retinitis Pigmentosa
  • Cochrane Library — Retinitis Pigmentosa
KA
Medical reviewer
Kathy Bacon

Reviewed this article for medical accuracy (2026-06-05).